| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.009 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.01 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |